Franc Šašek
Direttore/Membro del Consiglio presso KRKA, D. D.
Posizioni attive di Franc Šašek
Società | Posizione | Inizio | Fine |
---|---|---|---|
KRKA, D. D. | Direttore/Membro del Consiglio | 01/01/2009 | - |
Independent Dir/Board Member | 01/01/2009 | - | |
Direttore Tecnico/Scientifico/R&S | 01/01/1984 | - | |
KRKA Farmaceutici Milano SRL
KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Franc Šašek
Statistiche
Distribuzione geografica
Slovenia | 2 |
Italia | 2 |
Posizioni
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
KRKA, D. D. | Health Technology |
Aziende private | 1 |
---|---|
KRKA Farmaceutici Milano SRL
KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Health Technology |
- Borsa valori
- Insiders
- Franc Šašek
- Esperienza